Correlation Between Inozyme Pharma and Cingulate
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Cingulate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Cingulate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Cingulate, you can compare the effects of market volatilities on Inozyme Pharma and Cingulate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Cingulate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Cingulate.
Diversification Opportunities for Inozyme Pharma and Cingulate
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inozyme and Cingulate is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Cingulate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Cingulate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Cingulate go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Cingulate
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Cingulate. In addition to that, Inozyme Pharma is 1.42 times more volatile than Cingulate. It trades about -0.1 of its total potential returns per unit of risk. Cingulate is currently generating about 0.02 per unit of volatility. If you would invest 422.00 in Cingulate on September 15, 2024 and sell it today you would earn a total of 0.00 from holding Cingulate or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Inozyme Pharma vs. Cingulate
Performance |
Timeline |
Inozyme Pharma |
Cingulate |
Inozyme Pharma and Cingulate Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inozyme Pharma and Cingulate
The main advantage of trading using opposite Inozyme Pharma and Cingulate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Cingulate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate will offset losses from the drop in Cingulate's long position.Inozyme Pharma vs. Puma Biotechnology | Inozyme Pharma vs. Iovance Biotherapeutics | Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. Zentalis Pharmaceuticals Llc |
Cingulate vs. Puma Biotechnology | Cingulate vs. Iovance Biotherapeutics | Cingulate vs. Day One Biopharmaceuticals | Cingulate vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets |